0000874015-22-000074.txt : 20220214 0000874015-22-000074.hdr.sgml : 20220214 20220214181916 ACCESSION NUMBER: 0000874015-22-000074 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEIN JOSEPH III CENTRAL INDEX KEY: 0001206369 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 22635726 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 5 1 edgardoc.xml PRIMARY DOCUMENT X0306 5 2021-12-31 0 0 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001206369 KLEIN JOSEPH III 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 Common Stock 2021-11-30 5 G 0 6000 0.0 D 12126 D Common Stock 2021-11-30 5 G 0 6000 0.0 A 6000 I by Trust Common Stock 100 I by Son Non-Qualified Stock Option (right to buy) 24.42 2021-11-30 5 G 0 12000 0.0 D 2017-07-01 2026-06-30 Common Stock 12000 0 D Non-Qualified Stock Option (right to buy) 42.88 2021-11-30 5 G 0 12000 0.0 D 2019-07-02 2028-07-01 Common Stock 12000 4000 D Non-Qualified Stock Option (right to buy) 52.22 2021-11-30 5 G 0 16000 0.0 D 2018-07-03 2027-07-02 Common Stock 16000 0 D Non-Qualified Stock Option (right to buy) 57.16 2021-11-30 5 G 0 16000 0.0 D 2016-07-01 2025-06-30 Common Stock 16000 0 D Non-Qualified Stock Option (right to buy) 60.2 2021-11-30 5 G 0 12000 0.0 D 2021-07-01 2030-06-30 Common Stock 12000 0 D Non-Qualified Stock Option (right to buy) 64.8 2021-11-30 5 G 0 8000 0.0 D 2020-07-01 2029-06-30 Common Stock 8000 8000 D Non-Qualified Stock Option (right to buy) 24.42 2021-11-30 5 G 0 12000 0.0 A 2017-07-01 2026-06-30 Common Stock 12000 12000 I by Trust Non-Qualified Stock Option (right to buy) 42.88 2021-11-30 5 G 0 12000 0.0 A 2019-07-02 2028-07-01 Common Stock 12000 12000 I by Trust Non-Qualified Stock Option (right to buy) 52.22 2021-11-30 5 G 0 16000 0.0 A 2018-07-03 2027-07-02 Common Stock 16000 16000 I by Trust Non-Qualified Stock Option (right to buy) 57.16 2021-11-30 5 G 0 16000 0.0 A 2016-07-01 2025-06-30 Common Stock 16000 16000 I by Trust Non-Qualified Stock Option (right to buy) 60.2 2021-11-30 5 G 0 12000 0.0 A 2021-07-01 2030-06-30 Common Stock 12000 12000 I by Trust Non-Qualified Stock Option (right to buy) 64.8 2021-11-30 5 G 0 8000 0.0 A 2020-07-01 2029-06-30 Common Stock 8000 8000 I by Trust The reported transaction reflects the gift of shares to trusts for the benefit of the reporting person's three children, of which the reporting person's wife is a trustee. The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. The reported transactions reflect the gift of vested stock options to trusts for the benefit of the reporting person's three children, of which the reporting person's wife is a trustee. Grant of 7/2/18 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, with the first installment vesting on 7/2/19. The option shall be fully vested and exercisable on 7/2/22. The option was exercisable as to 12,000 shares on 11/30/21. Grant of 7/1/19 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, with the first installment vesting on 7/1/20. The option shall be fully vested and exercisable on 7/1/23. The option was exercisable as to 8,000 shares on 11/30/21. By: Patrick R. O'Neil, attorney-in-fact For: Joseph Klein III 2022-02-09